Inventor · disambiguated record
Mikhail Chafeev
Also filed as: CHAFEEV MIKHAIL · CHAFEEV MIKHAIL A · CHAFEEV MIKHAIL AIRATOVICH
31 granted patents·12 pending applications·501 citations·filing 2000–2020
97Inventor score
Files withXENON PHARMACEUTICALS INC20CHAFEEV MIKHAIL9ABBVIE INC3PRAMANA PHARMACEUTICALS INC3CADIEUX JEAN-JACQUES2
Top patents by PatentIndex Score
43 records- 0197US8883840B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Nov 11, 2014·63 cites·1 claims
- 0295US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0395US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0493US8450358B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2010·Granted May 28, 2013·17 cites·3 claims
- 0593US8101647B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 24, 2012·35 cites·37 claims
- 0692US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 0792US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0891US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 0991US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 1091US6436915B1Pyrazole compoundsKINETEK PHARMACEUTICALS INC·Filed 2000·Granted Aug 20, 2002·46 cites·26 claims
- 1189US10233179B2Thiazoles and uses thereofABBVIE INC·Filed 2014·Granted Mar 19, 2019·31 cites·37 claims
- 1289US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 1387US9630929B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·11 cites·29 claims
- 1487US8742109B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2012·Granted Jun 3, 2014·12 cites·6 claims
- 1585US9480677B2Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·5 cites·1 claims
- 1685US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 1784US11358956B2Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119PRAMANA PHARMACEUTICALS INC·Filed 2018·Granted Jun 14, 2022·3 cites·20 claims
- 1884US8445696B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2010·Granted May 21, 2013·9 cites·8 claims
- 1982US9695185B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·3 cites·1 claims
- 2082US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 2179US9260446B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·4 cites·5 claims
- 2279US7105503B2Pyrazole compoundsQUADRA LOGIC TECH INC·Filed 2002·Granted Sep 12, 2006·8 cites·29 claims
- 2378US10906894B2Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119PRAMANA PHARMACEUTICALS INC·Filed 2017·Granted Feb 2, 2021·3 cites·23 claims
- 2475US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 2573US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 2665US7875728B2Hydrazonopyrazole derivatives and their use as therapeuticsVALOCOR THERAPEUTICS INC·Filed 2002·Granted Jan 25, 2011·2 cites·5 claims
- 2758US12037328B2Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119PRAMANA PHARMACEUTICALS INC·Filed 2020·Granted Jul 16, 2024·0 cites·20 claims
- 2856US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2955US2017073351A1Enantiomers of spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3053US2011269788A1Spiro-oxindole-derivatives as sodium channel blockersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3153US2014107125A1Hydrazonopyrazole derivatives and their use as therapeuticsDERMIRA CANADA INC·Filed 2013·Application pending·0 cites
- 3253US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 3349US2009069408A1Tricyclic compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3449US2010240713A1Aromatic and heteroaromatic compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3548US2011237567A9Tricyclic spiro-oxindole derivatives and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3647US8445694B2Hydrazonopyrazole derivatives and their use as therapeuticsZHANG ZAIHUI·Filed 2010·Granted May 21, 2013·0 cites·7 claims
- 3747US2008234384A1Biaryl and biheteroaryl compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3846US10738049B2N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-D]pyrimidin-1-YL]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate as an MEK1/2 inhibitorR-PHARM JOINT STOCK COMPANY (R-PHARM JSC)·Filed 2016·Granted Aug 11, 2020·0 cites·8 claims
- 3943US2007105820A1Oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4043US2012035199A9Spiroheterocyclic compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2010·Application pending·0 cites
- 4143US2008103151A9Heterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4240US10112911B2Substituted cyanoguanidines as oral anti-viralsABBVIE INC·Filed 2013·Granted Oct 30, 2018·0 cites·18 claims
- 4339US9447051B2Diaminopyrimidines and uses thereofABBVIE INC·Filed 2013·Granted Sep 20, 2016·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →